PBAX Stock Ownership Activity

PHOENIX BIOTECH ACQUISI-CL A 13F holders

No value investing guru has made any change to the PHOENIX BIOTECH ACQUISI-CL A (PBAX) position according to the gurus' latest SEC quarterly report(s).

Which gurus or hedge funds are buying PBAX now?

According to the latest SEC filing(s) PHOENIX BIOTECH ACQUISI-CL A (PBAX) has not been purchased by any super investor.

To see more about who is investing in PHOENIX BIOTECH ACQUISI-CL A (PBAX), please go to the PBAX ownership page.

2022 Q1 (1 result)
Howard Marks
-100.00%
-199,000
-0.02%
0.00%
Current price: $5.85 40.97% Reported price*: $9.91
2021 Q4 (1 result)
Howard Marks
buy
+199,000
+0.03%
0.00%
Current price: $5.85 40.97% Reported price*: $9.91
2 of 2

Shares, change to shares, sold shares - split-adjusted.

Reported price - this doesn't represent the actual buy or sell price.
It is the split-adjusted price of the security as of the last day of the reported period.

Value or Price - If the security is completely sold out, we show the reported value (or price) prior to the actual period.